Valuation: DocMorris AG

Market Cap 403M 498M 437M 377M 707M 46.98B 721M 4.84B 1.87B 23.22B 1.87B 1.83B 80.51B P/E 2026 *
-5.21x
P/E 2027 * -9.36x
Enterprise Value 604M 748M 656M 566M 1.06B 70.54B 1.08B 7.26B 2.81B 34.86B 2.81B 2.75B 121B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.47x
Free-Float
65.88%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 498M
-3.50%-8.89%-24.58%-33.65% 13.03B
-3.76%-6.97%-32.82%-32.82% 6.33B
+0.72%+2.29%-17.98%-11.55% 5.8B
-2.83%-8.64%-23.00%-41.73% 3.24B
-0.69%-1.52%-26.98%-44.68% 3.26B
-2.49%-9.03%-38.84%-16.12% 3.14B
-7.04%-8.36%-6.86%-47.09% 2.48B
+8.82%-0.24%+100.05% - 2.68B
+1.61%+1.41%-15.86%-4.37% 2.5B
Average -0.92%-4.02%-9.65%-29.00% 4.72B
Weighted average by Cap. -1.73%-5.06%-16.61%-29.47%

Financials

2026 *2027 *
Net sales 1.22B 1.51B 1.32B 1.14B 2.14B 142B 2.18B 14.63B 5.66B 70.22B 5.66B 5.53B 244B 1.37B 1.69B 1.48B 1.28B 2.4B 160B 2.45B 16.44B 6.36B 78.92B 6.36B 6.22B 274B
Net income -84.17M -104M -91.32M -78.8M -148M -9.82B -151M -1.01B -391M -4.86B -391M -383M -16.84B -48.29M -59.74M -52.38M -45.21M -84.77M -5.64B -86.53M -580M -225M -2.79B -224M -219M -9.66B
Net Debt 202M 250M 219M 189M 354M 23.55B 362M 2.43B 939M 11.64B 938M 917M 40.37B 241M 298M 261M 225M 423M 28.09B 431M 2.89B 1.12B 13.88B 1.12B 1.09B 48.14B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.300CHF
Average target price
7.494CHF
Spread / Average Target
-9.71%

Quarterly revenue - Rate of surprise